Copyright
©The Author(s) 2016.
World J Methodol. Mar 26, 2016; 6(1): 43-55
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.43
Published online Mar 26, 2016. doi: 10.5662/wjm.v6.i1.43
Endometrial cancer | ||||||
African American women | Chinese women | |||||
Type I (n = 12) | Type II (n = 17) | Type I (n = 97) | Type II (n = 23) | |||
NILCO IHC | H SCORE | H SCORE | P value | H SCORE | H SCORE | P value |
Notch1 | 1.19 | 1.80 | < 0.01 | 1.00 | 1.78 | < 0.01 |
Notch2 | 1.10 | 1.30 | 0.05 | 1.00 | 1.15 | > 0.05 |
Notch3 | 1.15 | 1.45 | > 0.05 | 1.10 | 1.20 | > 0.05 |
Notch4 | 1.50 | 1.96 | < 0.01 | 1.10 | 1.58 | < 0.05 |
JAG1 | 1.36 | 2.20 | < 0.01 | 1.30 | 1.87 | < 0.01 |
DLL4 | 1.80 | 2.49 | < 0.01 | 1.31 | 1.80 | < 0.01 |
Survivin | 1.20 | 1.96 | < 0.01 | 1.17 | 1.60 | < 0.01 |
OB-R | 1.60 | 1.73 | < 0.01 | 1.10 | 1.50 | < 0.05 |
IL-1R tI | 1.28 | 2.00 | < 0.01 | 1.40 | 1.73 | < 0.05 |
Hey2 | 1.14 | 1.45 | < 0.01 | 1.07 | 1.30 | < 0.05 |
WB | Protein expression | Protein expression | P value | |||
Notch1 | 48 | 58 | < 0.05 | |||
Notch2 | 38 | 36 | > 0.05 | |||
Notch3 | 48 | 44 | > 0.05 | |||
Notch4 | 44 | 98 | < 0.01 | |||
JAG1 | 140 | 172 | < 0.05 | |||
DLL4 | 40 | 115 | < 0.01 | |||
Survivin | 131 | 230 | < 0.05 | |||
OB-R | 25 | 70 | < 0.01 | |||
IL-1R tI | 59 | 109 | < 0.05 | |||
Hey2 | 46 | 100 | < 0.01 | |||
qPCR | mRNA expression | mRNA expression | P value | |||
Notch1 | 1.00 | 1.30 | < 0.01 | |||
Notch3 | 0.45 | 0.80 | < 0.05 | |||
Notch4 | 0.80 | 1.40 | < 0.01 | |||
JAG1 | 0.05 | 0.52 | < 0.01 | |||
DLL4 | 1.10 | 1.50 | < 0.01 | |||
Survivin | 0.48 | 0.51 | < 0.05 | |||
OB-R | 0.45 | 0.65 | > 0.05 | |||
IL-1R tI | 0.82 | 1.56 | < 0.01 | |||
Hey2 | 0.03 | 0.62 | < 0.01 |
- Citation: Lipsey CC, Harbuzariu A, Daley-Brown D, Gonzalez-Perez RR. Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer. World J Methodol 2016; 6(1): 43-55
- URL: https://www.wjgnet.com/2222-0682/full/v6/i1/43.htm
- DOI: https://dx.doi.org/10.5662/wjm.v6.i1.43